Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vibeke, Backer"'
Publikováno v:
5.2 Monitoring Airway Disease.
Background: The American Thoracic society (ATS) recommends the use of FeNO in monitoring eosinophillic airway inflammation in patients with asthma. A decrease >20% for FeNO>50ppb or >10ppb for values Methods: All patients referred consecutively over
Publikováno v:
5.2 Monitoring Airway Disease.
Background Non-eosinophilic asthma is reported to be less responsive to steroid treatment than eosinophilic asthma, but little prospective evidence is available from real life populations. Aim: To compare the clinical outcomes in patients with non-eo
Publikováno v:
5.2 Monitoring Airway Disease.
Sputum eosinophils (Sp-Eos) and exhaled nitric oxide (FeNO) are usually regarded as two markers of airway inflammation that offer similar information. However, these inflammatory pathways can be activated differently: eosinophils through IL-5 and NO
Autor:
Pia Kiilerich, Celeste Porsbjerg, Asger Sverrild, Vibeke Backer, Anders Bergqvist, Karsten Kristiansen, Jonas S. Erjefält
Publikováno v:
5.2 Monitoring Airway Disease.
Rationale: The airway microbiota is altered in asthma, with less Bacteriodetes and more Proteobacteria than in healthy individuals. AHR to mannitol is related to eosinophilic airway inflammation and mast cell activation, but the relationship between